Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

The experimental pill ALZ-801 slowed memory decline by 50% and reduced brain shrinkage in early Alzheimer's patients with ...

Hundreds of participants gathered at Earl Brown Park in DeLand on a cooler Saturday morning for a walk to raise funds and ...

New results on the oral Alzheimer's pill, valiltramiprosate, claims it can slow down the brain atrophy that causes ...

The treatment, lecanemab, has already been approved in some other countries, including the U.S., the U.K., Japan, Mexico and ...

An international team of scientists has developed specialized nanoparticles that can reverse the cognitive symptoms of ...

Scientists have identified hundreds of genes that may increase the risk of developing Alzheimer's disease but the roles these ...

The community walks with Alzheimer's Association to raise funds that will go towards advancement for research in a cure.

Since 2013, for the Walk to End Alzheimer’s, the “Jevning Gems” team, led by Val Blomquist of Hallock, Minnesota, has raised $262,500 for research, education and resources ...

Staci Martin started having memory issues and “switching words” about 2 years ago but assumed it was perimenopause.

In this context, researchers have connected neurotoxins from algal blooms to brain changes associated with an ...

Researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas ...